Empagliflozin attenuates doxorubicin-impaired cardiac contractility by suppressing reactive oxygen species in isolated myocytes.

Lin, Rong; Peng, Xiaodong; Li, Yukun; Wang, Xuesi; Liu, Xinmeng; Jia, Xingze; Zhang, Chengjun; Liu, Nian; Dong, Jianzeng

Lin, Rong; Peng, Xiaodong; Li, Yukun; Wang, Xuesi; Liu, Xinmeng; Jia, Xingze; Zhang, Chengjun; Liu, Nian; Dong, Jianzeng.

Afiliación

Lin R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No 2. Anzhen Road, Chaoyang, 100029, Beijing, China.
Peng X; North China Medical & Health Group XingTai General Hospital, Xingtai, China.
Li Y; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Wang X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No 2. Anzhen Road, Chaoyang, 100029, Beijing, China.
Liu X; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Jia X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No 2. Anzhen Road, Chaoyang, 100029, Beijing, China.
Zhang C; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Liu N; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No 2. Anzhen Road, Chaoyang, 100029, Beijing, China.
Dong J; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.

Mol Cell Biochem ; 2023 Aug 30.

Article en En | MEDLINE | ID: mdl-37648958

Palabras clave

Ca2+ handling; Doxorubicin; Empagliflozin; Heart failure; ROS

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Cell Biochem Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google